Published in AIDS on August 03, 2016
The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA (2000) 7.65
Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology (1999) 5.55
Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clin Infect Dis (2002) 5.34
Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis (2001) 4.72
Anti-inflammatory effects of statins: clinical evidence and basic mechanisms. Nat Rev Drug Discov (2005) 3.92
Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut (2005) 2.90
Statin use is associated with a reduced risk of fibrosis progression in chronic hepatitis C. J Hepatol (2014) 2.85
Statins are associated with a reduced risk of hepatocellular cancer: a systematic review and meta-analysis. Gastroenterology (2012) 2.74
The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databases. Aliment Pharmacol Ther (2007) 2.59
HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis. Hepatology (2005) 2.42
Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes. Gastroenterology (2009) 2.39
Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort Study. Clin Infect Dis (2005) 2.35
Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy. Hepatology (2001) 2.29
Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy. J Hepatol (2005) 2.27
Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China. Int J Epidemiol (2004) 2.19
Incidence and predictors of severe liver fibrosis in human immunodeficiency virus-infected patients with chronic hepatitis C: a European collaborative study. Clin Infect Dis (2003) 2.11
Clinical Case Registries: simultaneous local and national disease registries for population quality management. J Am Med Inform Assoc (2009) 2.07
Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus. Clin Infect Dis (2000) 1.87
Viral hepatitis and HIV co-infection. Antiviral Res (2009) 1.85
Do type and duration of antiretroviral therapy attenuate liver fibrosis in HIV-hepatitis C virus-coinfected patients? Clin Infect Dis (2005) 1.66
Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus. Hepatology (2009) 1.64
Impact of antiretroviral treatment on progression of hepatic fibrosis in HIV/hepatitis C virus co-infected patients. AIDS (2004) 1.64
Primary liver cancer is more aggressive in HIV-HCV coinfection than in HCV infection. A prospective study (ANRS CO13 Hepavih and CO12 Cirvir). Clin Res Hepatol Gastroenterol (2011) 1.62
Yes! Statins can be given to liver patients. J Hepatol (2011) 1.56
Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients. Gut (2003) 1.48
Chemopreventive strategies in hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol (2013) 1.36
Meta-analysis: pioglitazone improves liver histology and fibrosis in patients with non-alcoholic steatohepatitis. Aliment Pharmacol Ther (2011) 1.21
Deaths among people with hepatitis C in New York City, 2000-2011. Clin Infect Dis (2014) 1.17
Sustained virological response to interferon plus ribavirin reduces non-liver-related mortality in patients coinfected with HIV and Hepatitis C virus. Clin Infect Dis (2012) 1.13
Hepatotoxicity fears contribute to underutilization of statin medications by primary care physicians. Am J Med Sci (2010) 1.12
A Systematic Review of the Usefulness of Statin Therapy in HIV-Infected Patients. Am J Cardiol (2015) 0.88
The effect of HIV viral control on the incidence of hepatocellular carcinoma in veterans with hepatitis C and HIV coinfection. J Acquir Immune Defic Syndr (2015) 0.83
Lipid dysregulation in hepatitis C virus, and impact of statin therapy upon clinical outcomes. World J Gastroenterol (2015) 0.82
Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States. Ann Intern Med (2011) 4.98
Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection. Gastroenterology (2010) 2.64
Patients referred to an urban HIV clinic frequently fail to establish care: factors predicting failure. AIDS Care (2005) 2.64
Abdominal obesity and the risk of Barrett's esophagus. Am J Gastroenterol (2005) 2.60
Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA (2007) 2.51
Obesity increases oesophageal acid exposure. Gut (2006) 2.42
Evaluation for liver transplantation: adherence to AASLD referral guidelines in a large Veterans Affairs center. Liver Transpl (2005) 2.06
Effectiveness of AFP and ultrasound tests on hepatocellular carcinoma mortality in HCV-infected patients in the USA. Gut (2011) 1.98
The Tingathe programme: a pilot intervention using community health workers to create a continuum of care in the prevention of mother to child transmission of HIV (PMTCT) cascade of services in Malawi. J Int AIDS Soc (2012) 1.92
Age at onset of GERD symptoms predicts risk of Barrett's esophagus. Am J Gastroenterol (2013) 1.80
The association between Barrett's esophagus and Helicobacter pylori infection: a meta-analysis. Helicobacter (2012) 1.74
The quality of care provided to patients with cirrhosis and ascites in the Department of Veterans Affairs. Gastroenterology (2012) 1.71
Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001. Arch Intern Med (2004) 1.70
Risk of colorectal cancer among Caucasian and African American veterans with ulcerative colitis. Inflamm Bowel Dis (2011) 1.53
Helicobacter pylori-negative gastritis: prevalence and risk factors. Am J Gastroenterol (2012) 1.51
Implementation and operational research: the impact of option B+ on the antenatal PMTCT cascade in Lilongwe, Malawi. J Acquir Immune Defic Syndr (2015) 1.47
HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. Veterans with HCV. Hepatology (2014) 1.46
Association between facility characteristics and the process of care delivered to patients with hepatitis C virus infection. Dig Dis Sci (2013) 1.41
Does HIV infection independently increase the incidence of lung cancer? Clin Infect Dis (2005) 1.32
Predictors of delayed HIV diagnosis in a recently diagnosed cohort. AIDS Patient Care STDS (2007) 1.27
Relationship of cosmetic procedures and drug use to hepatitis C and hepatitis B virus infections in a low-risk population. Hepatology (2006) 1.23
Surveillance for hepatocellular carcinoma: development and validation of an algorithm to classify tests in administrative and laboratory data. Dig Dis Sci (2010) 1.16
Visceral abdominal obesity measured by CT scan is associated with an increased risk of Barrett's oesophagus: a case-control study. Gut (2013) 1.14
Risk of immune thrombocytopenic purpura and autoimmune hemolytic anemia among 120 908 US veterans with hepatitis C virus infection. Arch Intern Med (2009) 1.06
Utilization and determinants of adjuvant therapy among older patients who receive curative surgery for pancreatic cancer. Pancreas (2009) 1.00
Low rates of mother-to-child HIV transmission in a routine programmatic setting in Lilongwe, Malawi. PLoS One (2013) 1.00
Level of α-fetoprotein predicts mortality among patients with hepatitis C-related hepatocellular carcinoma. Clin Gastroenterol Hepatol (2011) 0.99
Prevalence and predictors of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients. Hepatology (2013) 0.98
No significant effects of smoking or alcohol consumption on risk of Barrett's esophagus. Dig Dis Sci (2013) 0.96
Referral and receipt of treatment for hepatocellular carcinoma in United States veterans: effect of patient and nonpatient factors. Hepatology (2013) 0.96
Is there a race-based disparity in the survival of veterans with HIV? J Gen Intern Med (2006) 0.95
Process of care for hepatitis C infection is linked to treatment outcome and virologic response. Clin Gastroenterol Hepatol (2012) 0.94
The impact of HIV viral control on the incidence of HIV-associated anal cancer. J Acquir Immune Defic Syndr (2013) 0.94
Automated identification of surveillance colonoscopy in inflammatory bowel disease using natural language processing. Dig Dis Sci (2012) 0.92
Cumulative HIV viremia and non-AIDS-defining malignancies among a sample of HIV-infected male veterans. J Acquir Immune Defic Syndr (2014) 0.90
The incidence and prevalence of inflammatory bowel disease among U.S. veterans: a national cohort study. Inflamm Bowel Dis (2013) 0.89
Practice patterns of surveillance endoscopy in a Veterans Affairs database of 29,504 patients with Barrett's esophagus. Gastrointest Endosc (2012) 0.88
Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients. Hepatology (2014) 0.87
Dietary intake of vegetables, folate, and antioxidants and the risk of Barrett's esophagus. Cancer Causes Control (2013) 0.86
Fat mass by bioelectrical impedance analysis is not associated with increased risk of Barrett esophagus. J Clin Gastroenterol (2014) 0.86
Anal cancer incidence and survival: comparing the greater San-Francisco bay area to other SEER cancer registries. PLoS One (2013) 0.85
The effect of HIV viral control on the incidence of hepatocellular carcinoma in veterans with hepatitis C and HIV coinfection. J Acquir Immune Defic Syndr (2015) 0.83
Oral bisphosphonates and the risk of Barrett's esophagus: case-control analysis of US veterans. Am J Gastroenterol (2013) 0.81
Effect of immune reconstitution on the incidence of HIV-related Hodgkin lymphoma. PLoS One (2013) 0.80
Anal cytology as a predictor of anal intraepithelial neoplasia in HIV-positive men and women. Diagn Cytopathol (2013) 0.79
Hepatocellular carcinoma screening practices in the Department of Veterans Affairs: findings from a national facility survey. Dig Dis Sci (2013) 0.77
Increased thyroid cancer incidence corresponds to increased use of thyroid ultrasound and fine-needle aspiration: a study of the Veterans Affairs health care system. Cancer (2014) 0.77
Total Lifetime and Cancer-related Costs for Elderly Patients Diagnosed With Anal Cancer in the United States. Am J Clin Oncol (2015) 0.76
Anal dysplasia in HIV-infected women with cervical and vulvar dysplasia. J Low Genit Tract Dis (2004) 0.76
Duration of anal human papillomavirus infection among immunocompetent women: clues to anal cancer epidemiology and possible prevention strategies. Clin Infect Dis (2009) 0.76
A 2-item screen for depression in rehabilitation inpatients. Arch Phys Med Rehabil (2005) 0.76
Statin drugs decrease progression to cirrhosis in HIV/hepatitis C virus coinfected individuals. AIDS (2016) 0.76
Esophageal COX-2 expression is increased in Barrett's esophagus, obesity, and smoking. Dig Dis Sci (2014) 0.75
Age patterns of Kaposi's sarcoma incidence in a cohort of HIV-infected men. Cancer Med (2014) 0.75
Clinical and Economic Evaluation of Treatment Strategies for T1N0 Anal Canal Cancer. Am J Clin Oncol (2016) 0.75
Occupational exposure and the risk of Barrett's esophagus: a case-control study. Dig Dis Sci (2013) 0.75
Hepatitis C infection: dying with or from the infection? J Hepatol (2007) 0.75
Tuberculosis Screening and Reactivation Among a National Cohort of Patients with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Alpha Antagonists. Inflamm Bowel Dis (2017) 0.75
Malignancies in women with HIV infection. Curr Opin HIV AIDS (2017) 0.75